aHeart Disease Prevention Clinic, University of Minnesota, Minneapolis, Minnesota, USA
bMetabolic and Atherosclerosis Research Center, Cincinnati, Ohio, USA
cL-MARC Research Center, Louisville, Kentucky, USA
dPreventive Cardiovascular Medicine and Lipid Research Center, University of Pennsylvania, Philadelphia, USA
eAstraZeneca, Wilmington, Delaware, USA
Sponsorship: This study was supported by AstraZeneca LP, Wilmington, Delaware, USA. Crestor is a registered trademark of the AstraZeneca group of companies.
Correspondence and requests for reprints to Donald B. Hunninghake, MD, Heart Disease Prevention Clinic, University of Minnesota, MMC192 UMHC, 401 East River Parkway, Minneapolis, MN 55455, USA
Tel: +1 612 624 9661; fax: +1 612 624 7178;
e-mail: [email protected]
Received 01 August 2003 Revised 20 November 2003 Accepted 21 November 2003
